Camallergy
Food allergy represents a global unmet need affecting ~90m people. Camallergy develops what we regard as pioneering treatments to reduce their fear. Oral immunotherapy is the only technology to have achieved regulatory approval. Our medical device aims to revolutionise the delivery of the treatment.
Past Raises
| 2023 | £150,000 | Closed |
We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.
If you'd like your events, opportunities and news listed here please join free as an organisation.